VPH partners in two new EC projects: CHAIN and AIGENT
CHAIN and AIGENT kick off, strengthening European collaboration in artificial intelligence, digital twins and in silico medicine.
CHAIN and AIGENT kick off, strengthening European collaboration in artificial intelligence, digital twins and in silico medicine.
The initiative aims to reduce clinical trial timelines to less than four years through artificial intelligence, predictive computational models and adaptive trial designs.
Office of Health Economics's report highlights the potential health, economic and industry benefits of investing in the UK Centre of Excellence for In-Silico Regulatory Science and Innovation, provided adequate funding is secured.
The UK regulator plans new guidance and regulatory frameworks to advance computational evidence, digital twins and synthetic data in medicines development and clinical trials.
The HPP Thematic Network on "Building Responsible Ecosystem Solutions: AI and Virtual Human Twins in Healthcare" is entering its final phase and invites stakeholders to contribute their feedback to the draft Joint Statement.
The UK Centre of Excellence on In Silico Regulatory Science and Innovation (UK CEiRSI) kicked off its two-day training workshop in London on 14–15 October 2026, at the invitation of the International Medical Device Regulators Forum (IMDRF)
Bringing the European Virtual Human Twin community together in Brussels to share progress, strengthen collaboration and shape the next steps towards the Advanced VHT Platform.
The U.S. National Institutes of Health (NIH) is highlighting new research opportunities in Digital Twins for Biomedical, Biological, and Behavioral Research, supporting innovative approaches to accelerate scientific discovery and advance healthcare technologies.
As the European Union moves forward with revising Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR), the European Parliament’s Committee on Environment, Public Health and Food Safety (SANT) is taking a central role in recalibrating the MedTech regulatory landscape.
The European Medicines Agency (EMA) has initiated a voluntary pilot testing a revised model for Pre-Submission Interactions (PSI) ahead of initial Marketing Authorisation Applications (MAAs).
On 3 September 2026, during the VPH Conference in Milan, VPH hosted a plenary roundtable "From Credibility to Trust".
The European Commission’s Joint Research Centre (JRC) played an active role in the VPH2026 Conference, held in Milan, bringing its expertise in computational modelling and in silico medicine to discussions on the future of healthcare.